* Your assessment is very important for improving the workof artificial intelligence, which forms the content of this project
Download Public Health Guidance for Community
Survey
Document related concepts
Hospital-acquired infection wikipedia , lookup
Childhood immunizations in the United States wikipedia , lookup
Transmission (medicine) wikipedia , lookup
Globalization and disease wikipedia , lookup
Henipavirus wikipedia , lookup
Marburg virus disease wikipedia , lookup
Transcript
SARS Timeline Nov 16 ‘02 Feb 11 ‘03 Feb 28 First cases retrospectively Recognized, Guangdong, China March 11 March 12 March 19 March 27 April 5 Hong Kong and Vietnam report outbreaks in hospital workers Acute respiratory reported in Guangdong by China MOH WHO issues travel advisories Reported in U.S. and Europe April 17 April 28 Sequence of suspected agent, a coronavirus, established China coverup admitted; SARS made top priority WHO issues global alert First SARS case – Vietnam April 9 April 14 India SARS First SARS in Africa Vietnam containing virus (WHO) Case Distribution of SARS Worldwide ERSI, May 2003 ERSI, May 2003 Effect of Travel and Missed Cases on the SARS Epidemic Spread from Hotel M, Hong Kong Canada Guangdon g Province, China F,G A F,G 18 HCW 11 close contacts A Hong Kong SAR 95 HCW Hotel M Hong Kong A H,J H,J B >100 close contacts B Vietnam 37 HCW 21 close contacts K K Ireland 0 HCW I, L,M C,D,E C,D,E Singapor e 34 HCW 37 close contacts I,L,M United States 1 HCW SARS Hotspots (as of May 28, 2003) # Probable Cases # Deaths China Hong Kong Taiwan Singapore Canada United States Vietnam Philippines Other Countries 5322 1728 596 206 148 65 63 12 62 321 269 76 31 26 0 5 2 4 Total 8202 734 Number of SARS Cases Reported over Time (China) 250 200 150 100 50 10 5, 08 5, 06 5, 04 5, 02 5, 30 4, 28 4, 26 4, 24 4, 4, 22 0 Symptoms of SARS • • • • Cough High fever Severe pneumonia Difficult to distinguish from other respiratory diseases in early stages Incidence Difference across Different Age Groups (China) 35.0 (1/1,000,000) 29.2 30.0 25.0 21.5 18.7 20.0 18.0 16.1 16.5 6 0 - 7 0 - 15.0 10.0 7.2 5.0 1.6 0.0 0- 1 0 - 2 0 - 3 0 - 4 0 - 5 0 - CDC, 2003 Fatality Rates of Different Age Groups 30.0 28.0 26.3 25.0 20.0 17.6 15.0 10.0 10.0 5.0 5.0 3.0 0.0 0.0 0- 10- 0.9 0.0 20- 30- 40- 50- 60- 70- 80- CDC, 2003 Etiology SARS Diagnostics Key Messages • • • • SARS diagnostic assays are sensitive and specific, but may not provide definitive diagnosis early in the illness Changes in the quantity, type, and timing of specimens collected may improve detection of SARS-CoV infection Rapid and accurate diagnosis of other respiratory pathogens associated with SARS-like illness may help rule out SARSCoV infection and calm public fears Interpretation of test results must take into consideration possibility of false positives and negatives; a clear strategy to minimize such possibilities and to confirm test results are essential CDC, 2003 Peiris: personal communication Prevention of SARS Definitions of Quarantine Isolation • Separation and restricted movement of ill persons with contagious disease • Often in a hospital setting • Primarily individual level, may be populations Quarantine • Separation and restricted movement of well persons presumed exposed to contagion • Often at home, may be designated residential facility • Applied at the individual or community level May be voluntary or mandatory CDC, 2003 Modern Quarantine A collective action for the common good predicated on aiding individuals infected or exposed to infectious agents while protecting others from the dangers of inadvertent exposure Public good Civil liberties Meeting needs of individuals infected and exposed is paramount CDC, 2003 Key Issues to Consider • • • • • • • • • • Surveillance Clinical evaluation Infection control measures Patient isolation Engineering controls Exposure evaluation Staffing needs and personnel policies Access controls Supplies and equipment Communication CDC, 2003 SARS Mysteries Origin of SARS – animal reservoirs? Is coronavirus the etiologic agent? • Cases without antibody • Non-cases with antibody SARS Mysteries (continued) What proportion of exposed persons develop clinical disease and death? • Proportion of exposed, infected and asymptomatic Are there asymptomatic carriers? • Reports of cases without known source of exposure SARS Mysteries (continued) What causes “super shedders”? • Host characteristics; e.g., age • Agent characteristics – “virulent strain” Is pathology caused by the virus or the response to the virus? • AIDS patients appear to be resistant to SARS SARS Mysteries (continued) Will SARS reappear in the fall? • SARS is transmitted through the respiratory route. These diseases, like influenza, tend to have a season cycle with resurgence in the late fall, winter and early spring Will SARS Re-emerge? Potential sources of re-emergence • Animal reservoir • Humans with persistent infection • Unrecognized transmission in humans • Laboratory exposure SARS most likely to recur outside U.S. • Well-established global surveillance is important to recognition of first case